The bullish story here is that a new opportunity has emerged, especially in the Medicare Advantage market, for a new business model that serves patients better. It uses an integrated approach with value-based incentives in order to enable a better customer experience, and to save on costs by preventing hospitalizations.

More than 90% of the population lives within 5 miles of a pharmacy. There are about 327K pharmacists in the US and 486K total primary care providers (internal medicine, family medicine, pediatrics, etc.). Medicare beneficiaries, who are more likely to be on a recurring medication, see the pharmacist twice as often as their primary care physician. T... See more

Although the attractiveness of these products to consumers is clear, direct-to-consumer products bypass the typical filters and safeguards of health-care systems. The risk is that low value, or even harmful, products will inundate the commercial health-care market. There are cautionary instances of high-profile direct-to-consumer companies, such as... See more

Because COMPASS breaks big pharma’s model -- it involves expensive in-person treatment and doesn’t need to be prescribed over a long period of time -- none of the major pharmaceutical companies are competing with COMPASS in the space.